Viewing Study NCT06016920


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-25 @ 4:18 AM
Study NCT ID: NCT06016920
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2023-08-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Sponsor: Nykode Therapeutics ASA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module